PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 10:28 AM ET

Sponsor Check › Person

MM
No photo found yet (own website and image search run after this page is viewed)

Mark McDade

Named as an officer, director or promoter on SEC Form D filings · CA, MA, WA, PA · Sep 16, 2010 → Nov 18, 2025

10deals (issuers)
$467.7Mreported sold
129investors
20Form D filings
2010–2025years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 3:05 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Mark McDade is listed as a director on 20 SEC Form D filings by 10 issuers between Sep 2010 and Nov 2025. Largest by amount reported sold: Aimmune Therapeutics, Inc. (Brisbane, CA — other health care — 2018; $156.7M reported sold to 10 investors), Icosavax, Inc. (Seattle, WA — biotechnology — 2019–2021; $99.7M reported sold to 36 investors), Dermira, Inc. (Menlo Park, CA — other health care — 2014–2018; $51M reported sold to 15 investors), Amphivena Therapeutics, Inc. (South San Francisco, CA — other health care — 2018; $38.7M reported sold to 15 investors), Platelet BioGenesis, Inc. (Watertown, MA — industry reported as "Other" — 2017–2021; $35.4M reported sold to 34 investors) and 5 more (all listed below).

What this means That is a lot of deals — 10 separate companies raised money with this person listed as director, over about 15 years. Across those companies the filings report $467.7M sold in total.

Listed alongside Andrew L. Guggenhime (4 shared filings), Christopher M. Griffith (4 shared filings), David E. Cohen (4 shared filings), Eugene Bauer (4 shared filings), Fred Craves (4 shared filings) and 85 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Mark. Each name links to their own page.

2 of the issuers belong to the sponsor group Qiming (3 issuers, $0 reported sold, 2017–2021).

What this means A sponsor group is one team that sets up a new company for each deal. Qiming has 3 companies on file and $0 reported sold in total — the group page shows the whole track record in one place.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — 6 bankruptcy cases matching the name listed in Key records below.

What this means 6 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 20 public filings for Mark McDade and found 12 differences, 2 worth asking the sponsor about: 4 bankruptcy cases name the subject or team members; 7 Form Ds were filed more than 15 days after the first sale; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Mark McDade has not run yet — it is joining a line of 54,722 names; searches run around the clock at the hosts' allowed rate. Searched so far: 641 names.

Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 3:05 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Mark McDade..

State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).

3. Bankruptcies

6 cases: 6 closed (disposition not in docket feed)

Mark W McDade closed
United States Bankruptcy Court, M.D. Florida · No. 8:15-bk-08944 · Filed Aug 31, 2015 · Closed Dec 8, 2015
Role of Mark W McDade: Debtor · Outcome: Case closed 2015-12-08 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 9 federal dockets); 4 people with this name in Form D filings; court in FL (not a filing state)
Mark McDade closed
United States Bankruptcy Court, W.D. Texas · No. 11-11192 · Filed May 10, 2011 · Closed Jan 31, 2012
Role of Mark McDade: Debtor · Outcome: Case closed 2012-01-31 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 9 federal dockets); 4 people with this name in Form D filings; court in TX (not a filing state)
Mark J. McDade and Diana J. McDade closed
United States Bankruptcy Court, S.D. California · No. 09-14809 · Filed Sep 30, 2009 · Closed Jan 8, 2010
Role of Mark J. McDade and Diana J. McDade: Debtor · Outcome: Case closed 2010-01-08 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 9 federal dockets); 4 people with this name in Form D filings; court in the person's filing state (CA)
Mark W. McDade closed
United States Bankruptcy Court, C.D. Illinois · No. 05-94572 · Filed Oct 13, 2005 · Closed Jul 11, 2006
Role of Mark W. McDade: Debtor · Outcome: Case closed 2006-07-11 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 9 federal dockets); 4 people with this name in Form D filings; court in IL (not a filing state)
Mark F. McDade closed
United States Bankruptcy Court, W.D. Tennessee · No. 02-28308 · Filed May 17, 2002 · Closed Aug 27, 2003
Role of Mark F. McDade: Debtor · Outcome: Case closed 2003-08-27 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 9 federal dockets); 4 people with this name in Form D filings; court in TN (not a filing state)
Mark A. McDade and Tonya Bowen McDade closed
United States Bankruptcy Court, N.D. Oklahoma · No. 01-05087 · Filed Nov 8, 2001 · Closed Mar 12, 2002
Role of Mark A. McDade and Tonya Bowen McDade: Debtor · Outcome: Case closed 2002-03-12 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 9 federal dockets); 4 people with this name in Form D filings; court in OK (not a filing state)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 3:05 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

12 differences found between the filings for Mark McDade — 2 worth asking about (compared 20 filings on Oct 24, 2026)

Worth asking · Apr 3, 2000 – Jul 19, 2013

4 bankruptcy cases name the subject or team members

Bankruptcy case: Mark J. McDade and Diana J. McDade — filed Sep 30, 2009 · Bankruptcy case: NICHOLAS CARL REED and SARENA RENE REED — filed Mar 28, 2013 · Bankruptcy case: Christopher Shen and Yihsuan Ho — filed May 4, 2012 · Bankruptcy case: Howard S Soule and Paula L Soule — filed Apr 3, 2000

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Docket · United States Bankruptcy Court, S.D. California ↗Docket · United States Bankruptcy Court, E.D. California ↗Francis Sarena — PartnerFacts page ↗Docket · United States Bankruptcy Court, C.D. California ↗
Sources
Note · Jan 30, 2019 – Apr 21, 2021

Mark McDade appears on 2 deals that stopped filing before reaching their target

Qiming U.S. Healthcare Fund III, L.P. (last filing Apr 21, 2021; $0 sold of $300,000,000); Qiming U.S. Healthcare Fund II, L.P. (last filing Jan 30, 2019; $0 sold of $250,000,000). Each has no filing in more than two years and reported under half its target sold.

What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.

Qiming U.S. Healthcare Fund III, L.P. — PartnerFacts page ↗Qiming U.S. Healthcare Fund II, L.P. — PartnerFacts page ↗
Sources
Worth asking · Aug 3, 2010 – Nov 18, 2025

7 Form Ds were filed more than 15 days after the first sale

Form D filed 134 days after the first sale — Dualitas Therapeutics, Inc. · Form D filed 64 days after the first sale — Icosavax, Inc. · Form D filed 478 days after the first sale — Aimmune Therapeutics, Inc. · Form D filed 16 days after the first sale — Platelet BioGenesis, Inc. · Form D filed 19 days after the first sale — Icosavax, Inc. · and 2 more

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Form D · Nov 18, 2025 ↗Dualitas Therapeutics, Inc. — PartnerFacts page ↗Form D · Oct 18, 2019 ↗Icosavax, Inc. — PartnerFacts page ↗
Sources
Note · Aug 15, 2014 – Feb 5, 2021

4 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — WindMIL Therapeutics, Inc. (latest filing Feb 5, 2021) · No amendment in the last 12 months on an offering that may still be open — Icosavax, Inc. (latest filing Oct 18, 2019) · No amendment in the last 12 months on an offering that may still be open — Amphivena Therapeutics, Inc. (latest filing Dec 19, 2018) · No amendment in the last 12 months on an offering that may still be open — Dermira, Inc. (latest filing Sep 30, 2014)

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Feb 5, 2021 ↗WindMIL Therapeutics, Inc. — PartnerFacts page ↗Form D · Oct 18, 2019 ↗Icosavax, Inc. — PartnerFacts page ↗
Sources
Note · Jun 19, 2019 – Aug 13, 2019

Offering amount changed between filings — Platelet BioGenesis, Inc.

The Jun 19, 2019 filing says $11,364,976 offered; the Aug 13, 2019 Form D/A says $26,364,976.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D (earlier) · Jun 19, 2019 ↗Form D/A (later) · Aug 13, 2019 ↗Platelet BioGenesis, Inc. — PartnerFacts page ↗
Sources
Note · Sep 16, 2010 – Mar 26, 2014

Mark McDade is written 2 different ways on the filings

listed as "Mark McDade" on 15 filings (from Sep 16, 2010), and "Mark D. McDade" on 5 filings (from Mar 26, 2014).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · Sep 16, 2010 ↗Form D · Mar 26, 2014 ↗Mark McDade — PartnerFacts page ↗
Sources
Note · May 31, 2017 – Jun 19, 2019

Industry group changed between filings — Platelet BioGenesis, Inc.

"Biotechnology" (May 31, 2017); then "Other" (Jun 19, 2019 to Nov 4, 2021).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · May 31, 2017 ↗Form D · Jun 19, 2019 ↗Platelet BioGenesis, Inc. — PartnerFacts page ↗
Sources
Note · May 13, 2024 – Dec 16, 2024

Same name, different state: "Mark McDade" (IL) is a separate record

This page covers filings where the address state is CA or MA or WA or PA. A separate record, "Mark McDade" with address state IL, is listed on 2 filings — most recently by Soda Health, Inc. (Dec 16, 2024). Both records have filings in the same period (May 13, 2024 to Dec 16, 2024).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Mark McDade (IL) — PartnerFacts page ↗Form D · Dec 16, 2024 ↗Soda Health, Inc. — PartnerFacts page ↗Mark McDade (CA,MA,WA,PA) — this page ↗
Sources
Note · May 31, 2022 – May 21, 2024

Same name, different state: "Mark McDade" (OR) is a separate record

This page covers filings where the address state is CA or MA or WA or PA. A separate record, "Mark McDade" with address state OR, is listed on 2 filings — most recently by Boulder Care, Inc. (May 21, 2024). Both records have filings in the same period (May 31, 2022 to May 21, 2024).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Mark McDade (OR) — PartnerFacts page ↗Form D · May 21, 2024 ↗Boulder Care, Inc. — PartnerFacts page ↗Mark McDade (CA,MA,WA,PA) — this page ↗
Sources
Note · Oct 7, 2020

Same name, different state: "Mark McDade" (KY) is a separate record

This page covers filings where the address state is CA or MA or WA or PA. A separate record, "Mark McDade" with address state KY, is listed on 1 filing — most recently by Talaris Therapeutics, Inc. (Oct 7, 2020). Both records have filings in the same period (Oct 7, 2020).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Mark McDade (KY) — PartnerFacts page ↗Form D · Oct 7, 2020 ↗Talaris Therapeutics, Inc. — PartnerFacts page ↗Mark McDade (CA,MA,WA,PA) — this page ↗
Sources
Note · Sep 16, 2010 – Nov 4, 2021

4 address changes between filings

Address moved from Cambridge, MA to Watertown, MA — Platelet BioGenesis, Inc. · Address moved from Boston, MA to Cambridge, MA — Platelet BioGenesis, Inc. · Address moved from Redwood City, CA to Menlo Park, CA — Dermira, Inc. · Address moved from San Francisco, CA to South San Francisco, CA — FIVE PRIME THERAPEUTICS INC

What this means Businesses move. If you were told one city and the forms say another, ask which is current.

Form D/A · Aug 13, 2019 ↗Form D · Nov 4, 2021 ↗Platelet BioGenesis, Inc. — PartnerFacts page ↗Form D · May 31, 2017 ↗
Sources
Note · Sep 16, 2010 – Nov 18, 2025

Mark McDade is listed with 4 different address states: CA, MA, WA, PA

CA on 11 filings (Sep 16, 2010 to Nov 18, 2025); MA on 4 filings (May 31, 2017 to Nov 4, 2021); WA on 4 filings (Jan 30, 2019 to Apr 21, 2021); PA on 1 filing (Feb 5, 2021).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D · Sep 16, 2010 ↗Form D · May 31, 2017 ↗Form D · Jan 30, 2019 ↗Form D · Feb 5, 2021 ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

0 of 19 offerings report sales commissions; 1 reports finder's fees totalling $1,950,345; 1 reports proceeds to related persons totalling $600,000. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Nov 18, 2025 D
Dualitas Therapeutics, Inc.
File 021-564321
$0$0$0None listed on this filingEDGAR ↗
Nov 4, 2021 D
Platelet BioGenesis, Inc.
File 021-419730
$0$0$0None listed on this filingEDGAR ↗
Apr 21, 2021 D
Qiming U.S. Healthcare Fund III, L.P.
File 021-396659
$0$0$0
The General Partner (or its designee) is entitled to the payment of a management fee payable by the Issuer.
None listed on this filingEDGAR ↗
Apr 7, 2021 D
Icosavax, Inc.
File 021-394949
$0$0$0None listed on this filingEDGAR ↗
Feb 5, 2021 D
WindMIL Therapeutics, Inc.
File 021-388545
$0$0$0None listed on this filingEDGAR ↗
Oct 18, 2019 D
Icosavax, Inc.
File 021-351428
$0$0$0None listed on this filingEDGAR ↗
Aug 13, 2019 D/A
Platelet BioGenesis, Inc.
File 021-342330
$0$0$0None listed on this filingEDGAR ↗
Jan 30, 2019 D
Qiming U.S. Healthcare Fund II, L.P.
File 021-331749
$0$0$0
The General Partner (or its designee) is entitled to the payment of a management fee payable by the Issuer.
None listed on this filingEDGAR ↗
Dec 31, 2018 D
Dermira, Inc.
File 021-329222
$0$0$0None listed on this filingEDGAR ↗
Dec 19, 2018 D
Amphivena Therapeutics, Inc.
File 021-328368
$0$0$0None listed on this filingEDGAR ↗
Nov 29, 2018 D
Aimmune Therapeutics, Inc.
File 021-326810
$0$0$0n/a no CRD number reportedEDGAR ↗
Mar 16, 2018 D
Aimmune Therapeutics, Inc.
File 021-307907
$0$0$0N/A no CRD number reported
via N/A
EDGAR ↗
Dec 18, 2017 D
Dermira, Inc.
File 021-300967
$0$0$0None listed on this filingEDGAR ↗
May 31, 2017 D
Platelet BioGenesis, Inc.
File 021-287745
$0$0$600,000 (est.)
Executive Salaries
None listed on this filingEDGAR ↗
Sep 12, 2016 D
Dermira, Inc.
File 021-270454
$0$0$0None listed on this filingEDGAR ↗
Sep 30, 2014 D
Dermira, Inc.
File 021-225481
$0$1,950,345$0Leerink Partners LLC BrokerCheck CRD 39011 ↗EDGAR ↗
Mar 26, 2014 D
FIVE PRIME THERAPEUTICS INC
File 021-214271
$0$0$0None listed on this filingEDGAR ↗
Apr 20, 2012 D
FIVE PRIME THERAPEUTICS INC
File 021-177000
$0$0$0None listed on this filingEDGAR ↗
Sep 16, 2010 D
FIVE PRIME THERAPEUTICS INC
File 021-147844
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 10

Every issuer that named Mark McDade on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

DT
Biotechnology

Dualitas Therapeutics, Inc.

South San Francisco, CA · Nov 18, 2025
  • Nov 18, 2025 · D · $32,599,997 sold of $66,599,990 · 7 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $32.6M from 7 investors (49% of the $66.6M target) as of the latest filing. Mark is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

PB
Other

Platelet BioGenesis, Inc.

Watertown, MA · May 31, 2017 → Nov 4, 2021 · 4 filings
  • Nov 4, 2021 · D · $35,416,789 sold of $35,416,789 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 13, 2019 · D/A · $26,364,976 sold of $26,364,976 · 34 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 19, 2019 · D · $11,364,976 sold of $11,364,976 · 33 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 31, 2017 · D · $10,000,000 sold of $10,000,000 · 32 investors · min. $10,000 · role: Director EDGAR ↗

Raised $35.4M from 34 investors (100% of the $35.4M target) as of the latest filing. Mark is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

QU
Pooled Investment Fund · group: Qiming

Qiming U.S. Healthcare Fund III, L.P.

Bellevue, WA · Apr 21, 2021
  • Apr 21, 2021 · D · $0 sold of $300,000,000 · 0 investors · min. No minimum reported · role: Director (Managing Member of the General Partner) EDGAR ↗

No sales reported yet as of the latest filing. Mark is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

I
Biotechnology

Icosavax, Inc.

Seattle, WA · Oct 18, 2019 → Apr 7, 2021 · 2 filings
  • Apr 7, 2021 · D · $99,729,701 sold of $99,729,701 · 36 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 18, 2019 · D · $30,007,376 sold of $51,007,373 · 22 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $99.7M from 36 investors (100% of the $99.7M target) as of the latest filing. Mark is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

WT
Biotechnology

WindMIL Therapeutics, Inc.

Philadelphia, PA · Feb 5, 2021
  • Feb 5, 2021 · D · $2,334,814 sold of $5,000,000 · 11 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $32.5M from 11 investors (100% of the $5M target) as of the latest filing. Mark is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

QU
Pooled Investment Fund · group: Qiming

Qiming U.S. Healthcare Fund II, L.P.

Bellevue, WA · Jan 30, 2019
  • Jan 30, 2019 · D · $0 sold of $250,000,000 · 0 investors · min. No minimum reported · role: Director (Managing Member of the General Partner) EDGAR ↗

No sales reported yet as of the latest filing. Mark is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

D
Other Health Care

Dermira, Inc.

Menlo Park, CA · Sep 30, 2014 → Dec 31, 2018 · 4 filings
  • Dec 31, 2018 · D · $1,000,000 sold of $1,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 18, 2017 · D · $500,000 sold of $500,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 12, 2016 · D · $1,500,000 sold of $1,500,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 30, 2014 · D · $50,999,991 sold of $50,999,996 · 15 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $51M from 15 investors (100% of the $1M target) as of the latest filing. Mark is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AT
Other Health Care

Amphivena Therapeutics, Inc.

South San Francisco, CA · Dec 19, 2018
  • Dec 19, 2018 · D · $38,694,170 sold of $50,000,000 · 15 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $38.7M from 15 investors (77% of the $50M target) as of the latest filing. Mark is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AT
Other Health Care

Aimmune Therapeutics, Inc.

Brisbane, CA · Mar 16, 2018 → Nov 29, 2018 · 2 filings
  • Nov 29, 2018 · D · $98,000,002 sold of $98,000,002 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 16, 2018 · D · $156,700,012 sold of $156,700,012 · 2 investors · min. $1 · role: Director EDGAR ↗

Raised $156.7M from 10 investors (100% of the $98M target) as of the latest filing. Mark is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

FP
Biotechnology

FIVE PRIME THERAPEUTICS INC

South San Francisco, CA · Sep 16, 2010 → Mar 26, 2014 · 3 filings
  • Mar 26, 2014 · D · $21,040,488 sold of $21,040,488 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 20, 2012 · D · $10,000,000 sold of $10,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 16, 2010 · D · $7,499,999 sold of $7,499,999 · 1 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $21M from 1 investor (100% of the $21M target) as of the latest filing. Mark is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other pages with the same name (3)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Mark McDade — KY, 1 issuer, Oct 7, 2020 → Oct 7, 2020 · no shared issuer
  • Mark McDade — OR, 1 issuer, May 31, 2022 → May 21, 2024 · no shared issuer
  • Mark McDade — IL, 1 issuer, May 13, 2024 → Dec 16, 2024 · no shared issuer

People around Mark 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

PR
No photo found yet (own website and image search run after this page is viewed)
Person

Philip Reilly

Director · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Mark McDade. Their page shows their other deals.

MF
No photo found yet (own website and image search run after this page is viewed)
Person

Matthew Fust

Director · 4 shared filings (1 issuer) · also on 5 other issuers

Matthew Fust is on 6 issuers in total — a repeat sponsor. Their page lists every one.

TW
No photo found yet (own website and image search run after this page is viewed)
Person

Thomas G. Wiggans

Executive Officer, Director, Promoter · 4 shared filings (1 issuer) · also on 5 other issuers

Thomas G. Wiggans is on 6 issuers in total — a repeat sponsor. Their page lists every one.

WR
No photo found yet (own website and image search run after this page is viewed)
Person

William R. Ringo

Director · 4 shared filings (1 issuer)

Listed on the same filings as Mark McDade. Their page shows their other deals.

FC
No photo found yet (own website and image search run after this page is viewed)
Person

Fred Craves

Director · 4 shared filings (1 issuer) · also on 4 other issuers

Fred Craves is on 5 issuers in total — a repeat sponsor. Their page lists every one.

AG
No photo found yet (own website and image search run after this page is viewed)
Person

Andrew L. Guggenhime

Executive Officer · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Mark McDade. Their page shows their other deals.

CG
No photo found yet (own website and image search run after this page is viewed)
Person

Christopher M. Griffith

Executive Officer, Promoter · 4 shared filings (1 issuer)

Listed on the same filings as Mark McDade. Their page shows their other deals.

LP
No photo found yet (own website and image search run after this page is viewed)
Person

Luis Pena

Executive Officer, Promoter · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Mark McDade. Their page shows their other deals.

RM
No photo found yet (own website and image search run after this page is viewed)
Person

Richard Murray

Executive Officer, Director · 4 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Mark McDade. Their page shows their other deals.

JI
No photo found yet (own website and image search run after this page is viewed)
Person

Joseph Italiano

Director · 4 shared filings (1 issuer)

Listed on the same filings as Mark McDade. Their page shows their other deals.

EB
No photo found yet (own website and image search run after this page is viewed)
Person

Eugene Bauer

Executive Officer, Director, Promoter · 4 shared filings (1 issuer) · also on 10 other issuers

Eugene Bauer is on 11 issuers in total — a repeat sponsor. Their page lists every one.

DC
No photo found yet (own website and image search run after this page is viewed)
Person

David E. Cohen

Director · 4 shared filings (1 issuer)

Listed on the same filings as Mark McDade. Their page shows their other deals.

LW
No photo found yet (own website and image search run after this page is viewed)
Person

Lewis T. Williams

Executive Officer, Director · 3 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Mark McDade. Their page shows their other deals.

BA
No photo found yet (own website and image search run after this page is viewed)
Person

Brian Atwood

Director · 3 shared filings (1 issuer) · also on 14 other issuers

Brian Atwood is on 15 issuers in total — a repeat sponsor. Their page lists every one.

EM
No photo found yet (own website and image search run after this page is viewed)
Person

Eric Moessinger

Director · 3 shared filings (2 issuers) · also on 6 other issuers

Eric Moessinger is on 8 issuers in total — a repeat sponsor. Their page lists every one.

KS
No photo found yet (own website and image search run after this page is viewed)
Person

Kathleen Sebelius

Director · 3 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Mark McDade. Their page shows their other deals.

SK
No photo found yet (own website and image search run after this page is viewed)
Person

Sven Karlsson

Executive Officer, Director · 3 shared filings (1 issuer)

Listed on the same filings as Mark McDade. Their page shows their other deals.

FB
No photo found yet (own website and image search run after this page is viewed)
Person

Franklin Berger

Director · 3 shared filings (1 issuer) · also on 12 other issuers

Franklin Berger is on 13 issuers in total — a repeat sponsor. Their page lists every one.

JN
No photo found yet (own website and image search run after this page is viewed)
Person

Jake Nunn

Director · 2 shared filings (1 issuer) · also on 4 other issuers

Jake Nunn is on 5 issuers in total — a repeat sponsor. Their page lists every one.

BB
No photo found yet (own website and image search run after this page is viewed)
Person

Brook Byers

Director · 2 shared filings (1 issuer) · also on 21 other issuers

Brook Byers is on 22 issuers in total — a repeat sponsor. Their page lists every one.

FC
No photo found yet (own website and image search run after this page is viewed)
Person

Fred Cohen

Director · 2 shared filings (1 issuer) · also on 23 other issuers

Fred Cohen is on 24 issuers in total — a repeat sponsor. Their page lists every one.

RD
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Lee Douglas

Director · 2 shared filings (1 issuer)

Listed on the same filings as Mark McDade. Their page shows their other deals.

EB
No photo found yet (own website and image search run after this page is viewed)
Person

Eric H. Bjerkholt

Executive Officer · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Mark McDade. Their page shows their other deals.

DA
No photo found yet (own website and image search run after this page is viewed)
Person

Daniel C. Adelman

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Mark McDade. Their page shows their other deals.

FS
No photo found yet (own website and image search run after this page is viewed)
Person

Francis Sarena

Executive Officer · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Mark McDade. Their page shows their other deals.

KF
No photo found yet (own website and image search run after this page is viewed)
Person

Kathryn E. Falberg

Director · 2 shared filings (1 issuer)

Listed on the same filings as Mark McDade. Their page shows their other deals.

JN
No photo found yet (own website and image search run after this page is viewed)
Person

Jason Raleigh Nunn

Director · 2 shared filings (1 issuer)

Listed on the same filings as Mark McDade. Their page shows their other deals.

JT
No photo found yet (own website and image search run after this page is viewed)
Person

Jonathan Thon

Executive Officer, Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Mark McDade. Their page shows their other deals.

GR
No photo found yet (own website and image search run after this page is viewed)
Person

Gary Rieschel

Director · 2 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Mark McDade. Their page shows their other deals.

LW
No photo found yet (own website and image search run after this page is viewed)
Person

Lori Lyons-Williams

Executive Officer · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Mark McDade. Their page shows their other deals.

SB
No photo found yet (own website and image search run after this page is viewed)
Person

Susan E. Barrowcliffe

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Mark McDade. Their page shows their other deals.

GB
No photo found yet (own website and image search run after this page is viewed)
Person

Gregory Behar

Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Mark McDade. Their page shows their other deals.

MI
No photo found yet (own website and image search run after this page is viewed)
Person

Mark T. Iwicki

Director · 2 shared filings (1 issuer)

Listed on the same filings as Mark McDade. Their page shows their other deals.

MR
No photo found yet (own website and image search run after this page is viewed)
Person

Mary M. Rozenman

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Mark McDade. Their page shows their other deals.

DS
No photo found yet (own website and image search run after this page is viewed)
Person

Douglas T. Sheehy

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Mark McDade. Their page shows their other deals.

SR
No photo found yet (own website and image search run after this page is viewed)
Person

Sam Rasty

Director, Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Mark McDade. Their page shows their other deals.

JH
No photo found yet (own website and image search run after this page is viewed)
Person

Jason Hafler

Director · 2 shared filings (1 issuer)

Listed on the same filings as Mark McDade. Their page shows their other deals.

NT
No photo found yet (own website and image search run after this page is viewed)
Person

Niranjan Kanesa-thasan

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Mark McDade. Their page shows their other deals.

The team behind the deals

Q
Sponsor group

Qiming

3 issuers · 3 filings · $0 reported sold · 2017–2021

One team, 3 deal companies. Mark McDade is listed on 2 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Mark McDade.

Same business address

51 other issuers file from the same address (first 50 shown)

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Business registration (state registry / Secretary of State)

Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).

Adviser registration (Form ADV)

None of the 10 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Mark McDade by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 10 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Mark McDade is listed on: none on file. No website or social profile named in Aimmune Therapeutics, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #243,983 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Brisbane, CA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗California — find the county court ↗Los Angeles Superior Court case search ↗Massachusetts MassCourts ↗Washington Courts case search (dw.courts.wa.gov) ↗Pennsylvania UJS portal case search ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

California Secretary of State business search ↗Massachusetts Secretary of State business search ↗Washington Secretary of State business search ↗Pennsylvania Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Mark McDade appears on a new Form D, or when a court case or SEC action is matched to them. See plans →